FindTrial
Sign In

Correlation of FNAC, Core needle biopsy & BIRADS in breast malignancy.

Comparative study of fine needle aspiration cytology, core needle biopsy & BIRADS in diagnosis of clinically suspected breast malignancy.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053699
Enrollment
26
Registered
2023-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

None listed

Sponsors

Jawaharlal Nehru Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All clinically suspected cases of breast carcinoma.

Exclusion criteria

Exclusion criteria: 1. Already diagnosed cases of breast carcinoma. 2. Already operated cases of breast carcinoma. 3. All patients with breast carcinoma where the cancer is arising as a result of recurrence.

Design outcomes

Primary

MeasureTime frame
To study the correlation between FNAC, Core needle biopsy & BIRADS in breast Malignancy.Timepoint: 2 years—

Secondary

MeasureTime frame
To assess whether FNAC, Core needle biopsy are feasible for the suspected breast malignancy,Timepoint: 2 years—

Countries

India

Contacts

Public ContactDr Anil Agrawal

Jawaharlal Nehru Medical College (JNMC) , Wardha

dranilagrawal.456@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026